直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
Laura P. Masurovsky
Partner
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4043
laura.masurovsky@finnegan.com laura.masurovsky@finnegan.com

Laura P. Masurovsky

Partner

  • +1 202 408 4043 +1 202 408 4043
  • laura.masurovsky@finnegan.com laura.masurovsky@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

Laura Masurovsky is an experienced litigator with more than 25 years of practice in federal and state courts. She concentrates on patent infringement and trade secret cases and strategic counseling for portfolio growth. With a focus on the biomedical industry, Laura is an active member of Finnegan’s Israel practice.

Prior to joining Finnegan, Laura represented clients in commercial and white-collar criminal cases. She served as a special assistant U.S. attorney in the District of Columbia and as a legal advisor at the U.S. Department of State.

Laura previously served as a member of the firm’s management committee, as head of the litigation section, and as leader of the IP specialties practice group. She has been recognized by Managing Intellectual Property (MIP) as an “IP Star” and “Patent Star” on the national and regional levels as well as by The Legal 500 U.S. and Intellectual Asset Management (IAM) for her patent litigation and licensing work. The Federal Circuit Bar Association presented Laura with a Committee Leadership Award (CLA) and a Committee Individual Leadership Award (CILA) for her contributions to the Amicus Committee.

Et Cetera

  • Federal Circuit Bar Association (president, 2021-present; president-elect, 2020-2021; treasurer, 2019-2020; secretary, 2018-2019; ABA house delegate, 2013-2015; co-chair, Amicus Committee, 2011-2013; co-chair, Litigation Committee, 2008-2011.)
  • Adjunct professor of patent law, Haifa University, 2010-2013; and Howard University School of Law, 2005-2009.
  • Adjunct professor of trial advocacy, George Washington University Law School, 2001-2005.

Experience

Eli Lilly and Company v. Genentech, Inc.
Successfully represented Lilly in post-grant review (PGR) proceeding relating to patent on IL-17A/F antibodies that had been asserted against Lilly’s blockbuster Taltz® pharmaceutical and in parallel district court litigation. Achieved institution of PGR, judgment in favor of petitioner, and dismissal of the district court case.

PGR2019-00043, PTAB, Judges Mitchell, Paulraj, Cotta
3:18-cv-01518, S.D. Cal., Judge Sammartino

Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals
Represented Avid in suit concerning amyloid beta technology and its use in animal models in searching for drugs to treat Alzheimer's disease (AD). Won a jury verdict for Avid on issue of inventorship and patent ownership that was affirmed by the Federal Circuit, and obtained a finding of exceptional case, entitling Avid to an award of attorneys' fees. The verdict disposed of a series of suits against numerous companies involved in scientific research relating to Alzheimer's disease.

2:10-cv-06908, E.D. Pa., Judges Angell, Savage, Cohen (Special Master)
13-1544, 16-2647, Fed. Cir., Judges Hughes, Lourie, Moore, Newman, Plager

Cumberland Pharmaceuticals Inc. v. Mylan Institutional, LLC
Counsel for Cumberland in ANDA litigation and breach of contract arbitration. Successful outcome in bench trial, arbitration, arbitration fee award, and appeal.

16-1155, -1259, Fed. Cir., Judges Moore, Reyna, Taranto
1:12-cv-03846, N.D. Ill., Judge Pallmeyer

Eli Lilly and Company v. Actavis Elizabeth LLC
Successfully represented Lilly in ANDA case on patent covering Strattera®, a treatment for ADHD. Prevailed on appeal at the Federal Circuit, holding patent not invalid and that defendants infringed.

10-1500, -1520, -1521, -1522, -1523, -1524, Fed. Cir., Judges Lourie, Newman
2:07-cv-03770, D.N.J., Judges Cavanaugh, Dickson, Falk

Välinge Innovation AB v. Halstead New England Corporation, The Home Depot Inc. et al.
Represented global innovator of luxury vinyl tile and mechanical locking flooring in litigation to enforce a significant portfolio of patents. The case settled favorable shortly before trial.

1:16-cv-01082, D. Del., Judges Stark, Burke

Eli Lilly and Company v. Perrigo Co.

Co-lead counsel for plaintiffs in consolidated ANDA cases involving Axiron®.

1:13-cv-00851, S.D. Ind., Judges Barker, Dinsmore, LaRue

Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals

Represented Avid in suit concerning amyloid beta technology and its use in animal models in searching for drugs to treat Alzheimer's disease (AD). Won a jury verdict for Avid on issue of inventorship and patent ownership that was affirmed by the Federal Circuit, and obtained a finding of exceptional case, entitling Avid to an award of attorneys' fees. The verdict disposed of a series of suits against numerous companies involved in scientific research relating to Alzheimer's disease.

2:10-cv-06908, E.D. Pa., Judges Angell, Savage, Cohen (Special Master)
13-1544, 16-2647, Fed. Cir., Judges Hughes, Lourie, Moore, Newman, Plager

Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.

Represented Biogen in a Hatch-Waxman litigation involving 28 companies seeking FDA approval to market generic versions of Tecfidera®.

1:17-cv-00829, D. Del., Judge Noreika
1:17-cv-00116, N.D.W. Va., Judge Keeley

Cumberland Pharmaceuticals Inc. v. Mylan Institutional, LLC

Lead counsel for Cumberland in ANDA litigation and breach of contract arbitration. Successful outcome in bench trial, arbitration, arbitration fee award, and on appeal.

16-1155, -1259, Fed. Cir., Judges Moore, Reyna, Taranto
1:12-cv-03846, N.D. Ill., Judge Pallmeyer

Eli Lilly and Company v. Genentech, Inc.

Successfully represented Lilly in post-grant review (PGR) proceeding relating to patent on IL-17A/F antibodies that had been asserted against Lilly’s blockbuster Taltz® pharmaceutical and in parallel district court litigation. Achieved institution of PGR, judgment in favor of petitioner, and dismissal of the district court case.

PGR2019-00043, PTAB, Judges Mitchell, Paulraj, Cotta
3:18-cv-01518, S.D. Cal., Judge Sammartino

Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.

Successfully represented Eli Lilly and Company in Hatch-Waxman patent litigation relating to osteoporosis drug Forteo®.

1:16-cv-00596, S.D. Ind., Judges Pratt, Brookman

Välinge Innovation AB v. Halstead New England Corporation, The Home Depot Inc. et al.

Represented global innovator of luxury vinyl tile and mechanical locking flooring in litigation to enforce a significant portfolio of patents. The case settled favorable shortly before trial.

1:16-cv-01082, D. Del., Judges Stark, Burke

More

Insights

Webinar

Top Ten Mistakes to Avoid in Negotiating and Drafting License and Collaboration Agreements Top Ten Mistakes to Avoid in Negotiating and Drafting License and Collaboration Agreements

May 6, 2026

Webinar

Webinar

Strategies for Effectively Enhancing IP Value of Critical Assets After Teva v. Amneal and Other Recent Decisions Strategies for Effectively Enhancing IP Value of Critical Assets After Teva v. Amneal and Other Recent Decisions

June 11, 2025

Webinar

Articles

Strategies for Effectively Enhancing IP Value of Critical Assets after Teva v. Amneal and Other Recent Decisions

Strategies for Effectively Enhancing IP Value of Critical Assets after Teva v. Amneal and Other Recent Decisions Strategies for Effectively Enhancing IP Value of Critical Assets after Teva v. Amneal and Other Recent Decisions

May 20, 2025

The Marker

Books

Patent Litigation Strategies Handbook, 5th Edition Patent Litigation Strategies Handbook, 5th Edition

March 4, 2025

American Bar Association

Webinar

IP Challenges in Protecting Life Sciences Innovations IP Challenges in Protecting Life Sciences Innovations

September 18, 2024

Webinar

Articles

Global Patent Strategies in Light of Recent Case on Patent Term

Global Patent Strategies in Light of Recent Case on Patent Term Global Patent Strategies in Light of Recent Case on Patent Term

May 22, 2024

The Marker/Start Israel
More

News

Award/Ranking

Finnegan Remains a Top Tier Firm in the 2025 Managing Intellectual Property IP Stars Rankings

Finnegan Remains a Top Tier Firm in the 2025 Managing Intellectual Property IP Stars Rankings

May 30, 2025

Managing Intellectual Property

Award/Ranking

Finnegan Ranks at the Top of the Managing Intellectual Property IP Stars Rankings Finnegan Ranks at the Top of the Managing Intellectual Property IP Stars Rankings

June 28, 2024

Managing Intellectual Property

Press Release

Managing Intellectual Property IP Stars: Finnegan Scores Top Patent Rankings Across the Board Managing Intellectual Property IP Stars: Finnegan Scores Top Patent Rankings Across the Board

July 13, 2023

Managing Intellectual Property

Press Release

Finnegan Secures a Jury Win for Under Armour in Trademark Suit Finnegan Secures a Jury Win for Under Armour in Trademark Suit

January 24, 2023

Commentary

Litigator of the Week: Standing Strong for Under Armour’s Trademarks Without Going Overboard Against Upstart Armorina Litigator of the Week: Standing Strong for Under Armour’s Trademarks Without Going Overboard Against Upstart Armorina

January 20, 2023

The AmLaw Litigation Daily

Commentary

Under Armour Wins in TM Suit Against Armorina Under Armour Wins in TM Suit Against Armorina

January 13, 2023

Law360
More

Professional Activities

  • Federal Circuit Bar Association
    (president, 2021-present; president-elect, 2020-2021; treasurer, 2019-2020; secretary, 2018-2019; ABA house delegate, 2013-2015; co-chair, Amicus Committee, 2011-2013; co-chair, Litigation Committee, 2008-2011)
  • American Bar Association
  • American Intellectual Property Law Association
  • Women's Bar Association
Admissions and Education

Admissions

  • Virginia
  • Maryland
  • District of Columbia
  • New York
  • U.S. Court of Appeals, Federal Circuit
  • Supreme Court of the United States

Education

Harvard Law School
J.D., cum laude, 1983
Tufts University
B.A., French/Russian, summa cum laude, 1977

Languages

  • French
  • Russian

Laura's Practices

Appeals, Issues, and Legal Strategy
Federal Circuit and Supreme Court Appeals
Global IP Enforcement, Litigation, and Trials
Antitrust and Misuse
Branded Hatch-Waxman (ANDA) Litigation and Trials
Federal Circuit and Supreme Court Appeals
Patent Litigation and Trials
Pretrial Strategies
Trade Secrets
Prosecution and Portfolio Management
Licensing, Pooling, and Other Transactions
Trade Secrets

Laura's Industries

AI, Electronics, and Information Technology
Electrical and Computer Technology
Life Sciences
Medical Device and Diagnostics
Pharmaceutical

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP